retatrutide georgia (LY3437943) | GCGR/GIPR/GLP-1R Agonist Retatrutide Timeline: When to Expect

Novo Nordisk has received approval from the U.S

Unlike earlier medications like semaglutide (Ozempic) and tirzepatide (Mounjaro), retatrutide is designed to act on multiple hormone receptors simultaneouslyincluding GLP-1, GIP, and glucagon receptors

As I write this Im still recovering and waiting for the swelling to fully subside

Image Credit: Alexander_P / Shutterstock In a recent commentary article published in the journal Cell Reports Medicine , authors Maria J

On a GLP-1

Lilly became the first healthcare company worth a trillion dollars in late 2025, built substantially on tirzepatide, and in the first quarter of 2026 alone it booked $19.8 billion in revenue